Durac, Beverlyn B.

HRN: 11-42-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
CEFTRIAXONE 1G (VIAL)
09/30/2025
10/06/2025
IV
2 G
OD
Ovarian Torsion, For Pelvic Lap
Waiting Final Action 
10/01/2025
CEFTRIAXONE 1G (VIAL)
10/02/2025
10/03/2025
IVT
2gma
OD
S/p Pelvic Lap
Waiting Final Action 
10/01/2025
CEFUROXIME 500MG (TAB)
10/04/2025
10/11/2025
PO
500mg
BID
S/P Pelvic Lap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: